Fig. 2From: Long-term effects of peginterferon alfa-2a therapy in Japanese patients with chronic hepatitis B virus infectionALT levels of individual patients from pretreatment to end of treatment, and at 0.5, 1, 2, 3, 4 and 5 years after completion of treatment according to the duration of PEG-IFN treatment a with ALT levels rebound, b without ALT levels rebound. EOT: End of treatmentBack to article page